Galapagos

Developer of small molecule drugs for immunology and oncology

placeMechelen, Flanders, Belgium calendar_todayFounded 1999 groups449 employees language glpg.com

Social engagement

Social engagement: 85.5K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

19 investors on record; 2 have since exited.

Investor typeCountShare
Venture capital632%
Private equity421%
Other / undisclosed947%

Recent activity

6 May 2026
Event
Galapagos Conference Call and Webcast Presentation
31 Mar 2026
Partnership
Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
5 Mar 2026
Leadership hire
Chief Human Resources Officer
Coming soon